Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Purpose: The entity 'diffuse midline glioma, H3 K27M-mutant (DMG)' was introduced in the revised 4th edition of the 2016 WHO classification of brain tumors. However, there are only a few reports on magnetic resonance imaging (MRI) of these tumors. Thus, we conducted a retrospective survey focused on MRI features of DMG compared to midline glioblastomas H3 K27M-wildtype (mGBM-H3wt).
Methods: We identified 24 DMG cases and 19 mGBM-H3wt patients as controls. After being retrospectively evaluated for microscopic evidence of microvascular proliferations (MVP) and tumor necrosis by two experienced neuropathologists to identify the defining histological criteria of mGBM-H3wt, the samples were further analyzed by two experienced readers regarding imaging features such as shape, peritumoral edema and contrast enhancement.
Results: The DMG were found in the thalamus in 37.5% of cases (controls 63%), in the brainstem in 50% (vs. 32%) and spinal cord in 12.5% (vs. 5%). In MRI and considering MVP, DMG were found to be by far less likely to develop peritumoral edema (OR: 0.13; 95%-CL: 0.02-0.62) (p = 0.010). They, similarly, were associated with a significantly lower probability of developing strong contrast enhancement compared to mGBM-H3wt (OR: 0.10; 95%-CL: 0.02-0.47) (P = 0.003).
Conclusion: Despite having highly variable imaging features, DMG exhibited markedly less edema and lower contrast enhancement in MRI compared to mGBM-H3wt. Of these features, the enhancement level was associated with evidence of MVP.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336828 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0249647 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Microvessel density as a prognostic and predictive biomarker in newly diagnosed glioblastoma: correlations with radiological features and bevacizumab efficacy.
J Neurooncol
September 2025
Division of Neurosurgery, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Tottori, Japan.
Purpose: This study aimed to evaluate the prognostic significance of microvessel density (MVD), assessed by CD34 immunohistochemistry (IHC), and its correlation with radiological features and bevacizumab (BEV) treatment efficacy in newly diagnosed glioblastoma.
Methods: We retrospectively analyzed 41 patients with newly diagnosed glioblastoma. MVD was quantified using CD34 IHC, and patients were stratified into low and high MVD groups according to the cutoff value determined by receiver operating characteristic curve analysis (sensitivity, 76.
Exploring the Predictive Value of Grading in Regions Beyond Peritumoral Edema in Gliomas Based on Radiomics.
Curr Med Imaging
August 2025
Department of Medical Imaging Center, The First Affiliated Hospital of Medical College, Shihezi University, Medical Imaging Center, Shihezi, China.
Introduction: Accurate preoperative grading of adult-type diffuse gliomas is crucial for personalized treatment. Emerging evidence suggests tumor cell infiltration extends beyond peritumoral edema, but the predictive value of radiomics features in these regions remains underexplored.
Method: A retrospective analysis was conducted on 180 patients from the UCSF-PDGM dataset, split into training (70%) and validation (30%) cohorts.
Dexamethasone in brain tumor patients: a real-world pharmacovigilance audit.
Front Neurol
August 2025
Neurosurgical Department, King's College Hospital NHS Foundation Trust, London, United Kingdom.
Introduction: Dexamethasone is routinely prescribed for the management of peritumoral edema in brain tumor patients. Despite available orientations for its management in neuro-oncology patients, the individual needs according to the natural history of the disease and treatment options allied to a hierarchical system with multiple teams involved poses significant challenges in its real-world application.
Methods: We conducted a retrospective single-centre observational study of 316 brain tumor referrals to a tertiary neurosurgical center over a 3-month period.
Neurocognitive evaluation in patients with intracranial Meningiomas: A systematic review.
Brain Spine
August 2025
Department of Neurosurgery, University Hospital of Larissa, Larissa, 41110, Greece.
Introduction: Meningiomas remain the most frequently occurring intracranial, extra-axial, space-occupying lesions. Aspects such as neurocognitive function and quality of life become more and more crucial. Several meningioma patients present with evidence of neurocognitive impairment, behavioral disorders, or even psychiatric symptoms.
View Article and Find Full Text PDFPrediction of lymphovascular invasion in invasive breast cancer via intratumoral and peritumoral multiparametric magnetic resonance imaging machine learning-based radiomics with Shapley additive explanations interpretability analysis.
Quant Imaging Med Surg
September 2025
Department of Radiology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China.
Background: The use of multiparametric magnetic resonance imaging (MRI) in predicting lymphovascular invasion (LVI) in breast cancer has been well-documented in the literature. However, the majority of the related studies have primarily focused on intratumoral characteristics, overlooking the potential contribution of peritumoral features. The aim of this study was to evaluate the effectiveness of multiparametric MRI in predicting LVI by analyzing both intratumoral and peritumoral radiomics features and to assess the added value of incorporating both regions in LVI prediction.
View Article and Find Full Text PDF